Delivery Order SPE2DB22D3401-SPE2DB25FT0HZ
Award Date
10/24/24
Potential Completion Date
10/25/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,427.70 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a critical medical commodity. The contract has an ultimate completion date of November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $13,305.93 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566872449 ACTIVASE 100 MG VIALS, with a period of performance through January 9, 2025. The contract is a firm-fixed-price type without any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $5,935.94, is a delivery order for the medical product "ACTIVASE 50 MG VIALS" and has a period of performance through January 13, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,326.19 firm fixed-price delivery order is for the supply of ACTIVASE 50 MG VIALS, a medical product, with a period of performance through November 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $61,695.16, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the government - one with DLA Troop Support Medical valued up to $999,999,999.00 through 2025, and...
This federal contract award, valued at $44,385.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTIVASE 50 MG VIALS, a specialty pharmaceutical product, with a period of performance through December 10, 2024. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract, indicating open...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $11,631.98 for the delivery of ACTIVASE 100 MG VIALS. The contract has an ultimate completion date of April 22, 2024 and was awarded on April 19, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, an agency within the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $25,782.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of June 18, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of ACTIVASE 100 MG VIALS to the Defense Logistics Agency (DLA). The firm fixed price contract has a ceiling value of $12,009.36 and a completion date of March 15, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,864.71 firm fixed-price delivery order is for the supply of 50 mg vials of the pharmaceutical product Activase. The contract has a performance period through May 30, 2024 and does not include a set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal...